Αποτελέσματα Αναζήτησης
Low-dose aspirin (81 mg/day) prophylaxis is recommended in women at high risk of preeclampsia and should be initiated between 12 weeks and 28 weeks of gestation (optimally before 16 weeks) and continued daily until delivery.
12 Ιουλ 2022 · In view of its relevance, aspirin administration is commonly recommended to women at high risk for preeclampsia or FGR by the various national and international guidelines [7–22]. Clinical Practice Guidelines (CPGs) are statements that include recommendations intended to optimize patient care.
ACOG and SMFM also have provided more detailed information around timing, recommending that low-dose aspirin be initiated between 12 weeks and 28 weeks of gestation (optimally before 16 weeks) and continued daily until delivery 1. USPSTF 2021 Recommendation.
13 Ιαν 2023 · The American College of Obstetricians and Gynecologists recommends initiation of 81 mg of aspirin daily for women at risk of preeclampsia between 12 and 28 weeks’ gestation, optimally before 16 weeks, with continuation until delivery.
28 Σεπ 2021 · The USPSTF concludes with moderate certainty that there is a substantial net benefit of daily low-dose aspirin use to reduce the risk of preeclampsia, preterm birth, SGA, IUGR, and perinatal mortality in pregnant persons at high risk of preeclampsia.
Aspirin is currently recommended from 12 weeks gestation until the birth of the baby for women with one high, or two moderate risk factors for pre-eclampsia, to reduce the risk of developing the condition.
There is general agreement in the reported indications for aspirin intake in pregnancy, with prior preeclampsia and maternal medical co-morbidity associated with increased risk of preeclampsia being the major indications for aspirin intake.
